HTG Announces an Early Access Program for its Prototype Whole Transcriptome Panel

TUCSON, Ariz. , Dec. 08, 2020 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that it has launched an Early Access Program for its whole transcriptome panel using the HTG EdgeSeq